Resources
Safety data sheet (SDS)

ALPHALISA MBNL1 (HU) KIT, 500PTS

SKU: 08397741
  • Brand:
  • REVVITY
Discount -1.25%
2,627.74 € 2,661.00 € no VAT
Price subject to possible modifications
Pack/Lote: 1
Stock: 0 available
  You can order above the stock
Estimated delivery time: 19 days.
Manufacturer code
AL3008C
Sales measure
Unit
Presentation
500PTS
Weight
Not available
Filter by
Unit
Minimum price
Maximum price
Minimum weight
Maximum weight
500PTS
Lote: 1  |  Unit  | 
100PTS
Lote: 1  |  Unit  | 
5000PTS
Lote: 1  |  Unit  | 
Extended description
Formats:

 Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).
 Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (5 µL of sample).


Features:


 No-wash steps, no separation steps
 ELISA alternative technology
 Sensitive detection
 Broad sample compatibility
 Small sample volume
 Results in less than 3 hours
 Half the time of an ELISA assay


AlphaLISA technology allows the detection of molecules of interest in buffer, cell culture media, serum and plasma in a highly sensitive, quantitative, reproducible and user-friendly mode. In an AlphaLISA assay, a Biotinylated Anti-Analyte Antibody binds to the Streptavidin-coated Alpha Donor beads, while another Anti-Analyte Antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Muscleblind-like proteins (MBNL) belong to a family of tissue-specific precursor and mature mRNA metabolism regulators in mammals. Muscleblind-like Protein 1 (MBNL1) regulates alternative splicing of pre-mRNA; it is found primarily in skeletal and cardiac muscle tissues. Increased expression of MBNL1 has been linked to myotonic dystrophy, a particular type of muscular dystrophy. The present kit permits the detection of human MBNL1 (i.e. analyte) in cell culture media and samples.
Resources
Safety data sheet (SDS)